Shanghai Taichu Biotechnology

Shanghai Taichu Biotechnology

A company leading the non-clinical research of new drugs to Contract Development and Manufacturing Organization (CDMO) production.

Launch date
Market cap
-
Enterprise valuation
€175—263m (Dealroom.co estimates May 2023.)
Shanghai China (HQ)
  • Edit
DateInvestorsAmountRound

N/A

Seed

N/A

Seed

CNY300m

Seed
*

CNY350m

Series A
Total Funding€81.3m

Recent News about Shanghai Taichu Biotechnology

Edit